Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8126 items from SEC EDGAR · clear filters
- 8-K - Blackstone Infrastructure Strategies L.P. (0002030772) (Filer)
Blackstone Infrastructure Strategies L.P. filed a Form 8-K reporting unregistered sales of equity securities and included a Regulation FD disclosure.
- 8-K - Blackstone Infrastructure Strategies (TE) L.P. (0002050229) (Filer)
Blackstone Infrastructure Strategies (TE) L.P. filed a Form 8-K on September 29, 2026, reporting unregistered sales of equity securities and including a Regulation FD disclosure.
- 8-K - CANADIAN PACIFIC KANSAS CITY LTD/CN (0000016875) (Filer)
Canadian Pacific Kansas City Ltd filed a Form 8-K on September 29, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - ONE Gas, Inc. (0001587732) (Filer)
ONE Gas, Inc. filed a Form 8-K on September 29, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits as required under Items 7.01 and 9.01.
- 8-K - Xylem Inc. (0001524472) (Filer)
Xylem Inc. filed a Form 8-K on September 29, 2026 (Accession No. 0001524472-26-000134, 926 KB), including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - HINES GLOBAL INCOME TRUST, INC. (0001585101) (Filer)
Hines Global Income Trust, Inc. filed a Form 8-K on September 29, 2026, reporting a submission of matters to a security-holder vote (Item 5.07), a Regulation FD disclosure (Item 7.01), and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Lexeo Therapeutics, Inc. (0001907108) (Filer)
Lexeo Therapeutics filed a Form 8-K reporting the completion of an acquisition or disposition of assets, unregistered sales of equity securities, and the inclusion of financial statements and related exhibits.
- 8-K - Apyx Medical Corp (0000719135) (Filer)
Apyx Medical Corp filed a Form 8-K on September 29, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Stablecoin Development Corp (0001389545) (Filer)
Stablecoin Development Corp filed a Form 8-K on September 29, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Avalanche Treasury Corp (0002092446) (Filer)
Avalanche Treasury Corp filed a Form 8-K with the SEC on September 29, 2026, reporting under Item 8.01 (Other Events) as accession number 0001104659-26-111940.
- 8-K - VERIZON COMMUNICATIONS INC (0000732712) (Filer)
Verizon Communications filed an 8-K on September 29, 2026 reporting the departure of certain directors or officers, the election or appointment of directors, and disclosed compensatory arrangements for specific officers.
- 8-K - Meridian Holdings Inc./NV (0001437925) (Filer)
Meridian Holdings Inc./NV filed a Form 8-K with the SEC on September 29 2026 (Accession No. 0001477932-26-005898), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.
- 8-K - nVent Electric plc (0001720635) (Filer)
nVent Electric plc filed a Form 8-K on September 29, 2026, disclosing a direct financial obligation or off-balance-sheet arrangement, other events, and accompanying financial statements and exhibits.
- 8-K - Apimeds Pharmaceuticals US, Inc. (0001894525) (Filer)
Apimeds Pharmaceuticals US, Inc. filed a Form 8-K on September 29, 2026 (Accession No. 0001213900-26-104668, 253 KB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.
- 8-K - Constellation Acquisition Corp I (0001834032) (Filer)
Constellation Acquisition Corp I filed a Form 8-K on September 29, 2026, disclosing the creation of a direct financial obligation or an off-balance-sheet arrangement as required under Item 2.03.
- 8-K - Advanced Flower Capital Inc. (0001822523) (Filer)
Advanced Flower Capital Inc. filed a Form 8-K on September 29, 2026 reporting a material definitive agreement, the creation of a direct financial obligation/off-balance-sheet arrangement, and accompanying financial statements and exhibits.
- 8-K - DYNEX CAPITAL INC (0000826675) (Filer)
Dynex Capital Inc. filed a Form 8-K reporting material modifications to security holders' rights, amendments to its charter and bylaws including a fiscal year change, other events, and accompanying financial statements and exhibits.
- 8-K - LIFECORE BIOMEDICAL, INC. \DE\ (0001005286) (Filer)
LifeCore Biomedical, Inc. filed a Form 8-K on September 29, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - Bluerock Acquisition Corp. II (0002098410) (Filer)
Bluerock Acquisition Corp. II filed a Form 8-K reporting a material definitive agreement, unregistered equity sales, changes to directors and officers, amendments to its charter and bylaws, a fiscal year change, other events, and accompanying financial statements.
- 8-K - InPoint Commercial Real Estate Income, Inc. (0001690012) (Filer)
InPoint Commercial Real Estate Income, Inc. filed a Form 8-K reporting an Item 8.01 “Other Events” with the SEC on September 29, 2026 (Accession No. 0001193125-26-407484).
- 8-K - KKR Infrastructure Conglomerate LLC (0001948056) (Filer)
KKR Infrastructure Conglomerate LLC filed a Form 8-K with the SEC on September 29, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001948056-26-000079, 134 KB).
- 8-K - Concentrix Corp (0001803599) (Filer)
Concentrix Corp filed a Form 8-K on September 29, 2026, containing Item 2.02 results of operations and financial condition, and Item 9.01 financial statements and related exhibits.
- 8-K - Graf Global Corp. (0001897463) (Filer)
Graf Global Corp. filed a Form 8-K under Item 8.01 (Other Events) with the SEC on September 29, 2026, accession number 0001104659-26-111929, accompanying a 250 KB document.
- 8-K - Modular Medical, Inc. (0001074871) (Filer)
Modular Medical, Inc. filed a Form 8-K on September 29, 2026 disclosing the departure of certain directors or officers, the election and appointment of directors and officers, and related compensatory arrangements for those officers.
- 8-K - Dyne Therapeutics, Inc. (0001818794) (Filer)
Dyne Therapeutics, Inc. filed a Form 8-K on September 29, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - IPC Alternative Real Estate Income Trust, Inc. (0001959961) (Filer)
IPC Alternative Real Estate Income Trust, Inc. filed a Form 8-K under Item 8.01 (Other Events) with the SEC on September 29, 2026 (Accession No. 0001193125-26-407222).
- 8-K - GOLDENWELL BIOTECH, INC. (0001800373) (Filer)
Goldenwell Biotech, Inc. filed a Form 8-K on September 29, 2026, reporting a change in its certifying public accountant and providing its financial statements and accompanying exhibits.
- 8-K/A - Catalyst Bancorp, Inc. (0001849867) (Filer)
Catalyst Bancorp, Inc. filed a Form 8-K/A on September 29 2026 (Accession No. 0001849867-26-000022), providing updated financial statements and related exhibits in accordance with Item 9.01.
- 8-K - LAGO Evergreen Credit (0002043759) (Filer)
LAGO Evergreen Credit filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, and the inclusion of financial statements and related exhibits.
- 8-K - Reynaldo's Mexican Food Company, Inc. (0001283789) (Filer)
Reynaldo's Mexican Food Company, Inc. filed a Form 8-K reporting a change in its certifying accountant and disclosing the departure, election, appointment, and compensation arrangements of certain directors and officers.